Filtered By:
Therapy: Stem Cell Therapy

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 25607 results found since Jan 2013.

Industry Update: Latest developments in stem cell research and regenerative medicine
Regenerative Medicine , January 2014, Vol. 9, No. 1, Pages 17-22.
Source: Future Medicine: Regenerative Medicine - December 18, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Fgf10: A Paracrine-signaling Molecule in Development, Disease, and Regenerative Medicine.
Abstract The Fgf family comprises 22 members with diverse functions in development, repair, metabolism, and neuronal activities. Fgf10 mediates biological responses by activating Fgf receptor 2b (Fgfr2b) with heparin/heparan sulfate in a paracrine manner. Fgf10 and Fgfr2b are expressed in mesenchymal and epithelial tissues, respectively. Fgf10 is an epithelial-mesenchymal signaling molecule. Fgf10 knockout mice show severe phenotypes with complete truncation of the fore- and hindlimbs and die shortly after birth due to impaired lung development, indicating that Fgf10 serves as an essential regulator of lung and li...
Source: Current Molecular Medicine - April 14, 2014 Category: Molecular Biology Authors: Itoh N, Ohta H Tags: Curr Mol Med Source Type: research

Industry Update: Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions from 1 November 2013 until 31 December 2013
Regenerative Medicine , March 2014, Vol. 9, No. 2, Pages 137-143.
Source: Future Medicine: Regenerative Medicine - April 22, 2014 Category: Genetics & Stem Cells Tags: article Source Type: research

Industry Update: Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions from 1 January 2013 until 28 February 2014
Regenerative Medicine May 2014, Vol. 9, No. 3, Pages 259-265.
Source: Future Medicine: Regenerative Medicine - June 17, 2014 Category: Genetics & Stem Cells Tags: article Source Type: research

Advancing regenerative medicine
Nature Medicine 20, 795 (2014). doi:10.1038/nm.3658 Regenerative medicine may enable replacement of damaged or diseased tissues. But its clinical success will require deeper understanding of the basic biology of the stem cell niche and coordination between stem cell biologists and those in other fields.
Source: Nature Medicine - August 6, 2014 Category: Journals (General) Tags: Editorial Source Type: research

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions from March 1, 2014 until April 30, 2014
Regenerative Medicine July 2014, Vol. 9, No. 4, Pages 417-422.
Source: Future Medicine: Regenerative Medicine - August 27, 2014 Category: Genetics & Stem Cells Tags: article Source Type: research

Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy
Regenerative Medicine July 2014, Vol. 9, No. 4, Pages 453-465.
Source: Future Medicine: Regenerative Medicine - August 27, 2014 Category: Genetics & Stem Cells Tags: article Source Type: research

Exploring innovation in stem cell and regenerative medicine in Japan: the power of the consortium-based approach
Regenerative Medicine July 2014, Vol. 9, No. 4, Pages 467-477.
Source: Future Medicine: Regenerative Medicine - August 27, 2014 Category: Genetics & Stem Cells Tags: article Source Type: research

Stem Cells, Malaria, and the Genetics of Drug Response at Translational Medicine Symposium
(University of Pennsylvania School of Medicine) The University of Pennsylvania's Institute for Translational Medicine and Therapeutics' 9th Annual International Symposium, Progress in Translational Science: Emerging Therapeutic Modalities, will be held on Oct. 13-14. The symposium will feature outstanding speakers from the United States and abroad to address topics at the core of translational science. Speakers will include experts researching advances in stem cell biology, single cell metabolomics, and infectious diseases.
Source: EurekAlert! - Medicine and Health - October 6, 2014 Category: Global & Universal Source Type: news

Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis
Publication date: May 2014 Source:Journal of Integrative Medicine, Volume 12, Issue 3 Author(s): Shu Dong , Shi-bing Su Liver fibrosis is a primary cause of liver cirrhosis, and even hepatocarcinoma. Recently, the usage of mesenchymal stem cells (MSCs) has been investigated to improve liver fibrosis. It has been reported that the differentiation, proliferation and migration of MSCs can be regulated by traditional Chinese medicine treatment; however, the mechanisms are still unclear. In this article, the authors review the characteristics of MSCs such as multidirectional differentiation and homing, and its application in ...
Source: Journal of Integrative Medicine - November 3, 2014 Category: Complementary Medicine Source Type: research

The relevance and potential roles of microphysiological systems in biology and medicine
Microphysiological systems (MPS), consisting of interacting organs-on-chips or tissue-engineered, 3D organ constructs that use human cells, present an opportunity to bring new tools to biology, medicine, pharmacology, physiology, and toxicology. This issue of Experimental Biology and Medicine describes the ongoing development of MPS that can serve as in-vitro models for bone and cartilage, brain, gastrointestinal tract, lung, liver, microvasculature, reproductive tract, skeletal muscle, and skin. Related topics addressed here are the interconnection of organs-on-chips to support physiologically based pharmacokinetics and d...
Source: Experimental Biology and Medicine - September 3, 2014 Category: Research Authors: Wikswo, J. P. Tags: Introduction Source Type: research

Keck Medicine of USC researchers win $4.3 million for stem cell research
(University of Southern California - Health Sciences) Three scientists from Keck Medicine of the University of Southern California have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine for research that includes creating a temporary liver for transplant patients, finding novel ways to treat immune disorders and blood diseases and developing a new animal model for exploring diseases like heart failure, diabetes and neurodegenerative diseases.
Source: EurekAlert! - Medicine and Health - February 4, 2015 Category: Global & Universal Source Type: news

Avoiding immunological rejection in regenerative medicine.
Abstract One of the major goals of regenerative medicine is repair or replacement of diseased and damaged tissues by transfer of differentiated stem cells or stem cell-derived tissues. The possibility that these tissues will be destroyed by immunological rejection remains a challenge that can only be overcome through a better understanding of the nature and expression of potentially immunogenic molecules associated with cell replacement therapy and the mechanisms and pathways resulting in their immunologic rejection. This review draws on clinical experience of organ and tissue transplantation, and on transplantati...
Source: Regenerative Medicine - May 1, 2015 Category: Genetics & Stem Cells Authors: Bolton EM, Bradley JA Tags: Regen Med Source Type: research

Keck School of Medicine of USC postdoctoral fellow receives first Hearst Fellowship
(University of Southern California - Health Sciences) Albert D. Kim, Ph.D., a postdoctoral fellow at the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at the University of Southern California, is the first Keck School of Medicine of USC researcher to win a Hearst Fellowship for his work investigating how to turn stem cells into nephrons, the functional units of the kidney.
Source: EurekAlert! - Medicine and Health - September 25, 2015 Category: Global & Universal Source Type: news

Ultrasound-Assisted Liposuction Does Not Compromise the Regenerative Potential of Adipose-Derived Stem Cells
Human mesenchymal stem cells (MSCs) have recently become a focus of regenerative medicine, both for their multilineage differentiation capacity and their excretion of proregenerative cytokines. Adipose-derived mesenchymal stem cells (ASCs) are of particular interest because of their abundance in fat tissue and the ease of harvest via liposuction. However, little is known about the impact of different liposuction methods on the functionality of ASCs. Here we evaluate the regenerative abilities of ASCs harvested via a third-generation ultrasound-assisted liposuction (UAL) device versus ASCs obtained via standard suction-assi...
Source: Stem Cells Translational Medicine - January 27, 2016 Category: Stem Cells Authors: Duscher, D., Atashroo, D., Maan, Z. N., Luan, A., Brett, E. A., Barrera, J., Khong, S. M., Zielins, E. R., Whittam, A. J., Hu, M. S., Walmsley, G. G., Pollhammer, M. S., Schmidt, M., Schilling, A. F., Machens, H.-G., Huemer, G. M., Wan, D. C., Longaker, M Tags: Tissue Engineering and Regenerative Medicine, Adipose-Derived Stem Cells Source Type: research